Long‐term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real‐world, single‐center experience

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

(2020) Abby S. Van Voorhees et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Apremilast as a potential treatment option for COVID ‐19: no symptoms of infection in a psoriatic patient

(2020) O. Yu. Olisova et al.   Dermatologic Therapy

Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID ‐19 pandemic

(2020) Daniele Melis et al.   Dermatologic Therapy

The global, regional, and national burden of psoriasis in 195 countries and territories, 1990–2017: A systematic analysis from the Global Burden of Disease Study 2017

(2020) Sino Mehrmal et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period

(2020) M. Megna et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Characteristics and Outcomes of Patients Treated With Apremilast in the Real World: Results From the APPRECIATE Study

(2020) M. Augustin et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicenter study by the Spanish Psoriasis Group

(2020) Elena del Alcázar et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Novel Therapeutic Approaches And Targets For Treatment Of Psoriasis

(2020) G. Radi et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

COVID ‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain

(2020) Rubén Queiro Silva et al.   Dermatologic Therapy

Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting

(2019) Giulia Radi et al.   GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

Real‐world experiences of apremilast in clinics for Japanese patients with psoriasis

(2019) Hiroshi Saruwatari   JOURNAL OF DERMATOLOGY

A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective study

(2018) Arvin Ighani et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study

(2018) K. Reich et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis

(2018) E. Papadavid et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic

(2018) Michele Maria Luchetti et al.   CLINICAL RHEUMATOLOGY

Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis

(2018) Chika Ohata et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

(2017) Jeffrey Crowley et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Apremilast in psoriasis - a prospective real-world study

(2017) I. Vujic et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Adalimumab Modulates Angiogenesis in Psoriatic Skin

(2017) A. Campanati et al.   European Journal of Inflammation

Real-World Experience With Apremilast in Treating Psoriasis

(2016) Julia N. Mayba et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study

(2016) A. Campanati et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)

(2016) Phoebe Rich et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis

(2016) L. Puig et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)

(2016) K. Reich et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry

(2015) P. Gisondi et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)

(2015) C. Paul et al.   BRITISH JOURNAL OF DERMATOLOGY

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

(2015) Kim Papp et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Homocysteine plasma levels in psoriasis patients: our experience and review of the literature

(2015) M. Giannoni et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Involvement of the oral cavity in psoriasis: results of a clinical study

(2014) G. Ganzetti et al.   BRITISH JOURNAL OF DERMATOLOGY

PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithm

(2014) D. Linder et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Insulin resistance, serum insulin and HOMA-R

(2013) A. Campanati et al.   JOURNAL OF GASTROENTEROLOGY

Psoriasis Severity and the Prevalence of Major Medical Comorbidity

(2013) Howa Yeung et al.   JAMA Dermatology